TMC-558445

N/A

Report date: 2024/12/06 20:00:46
NME

Base Information

Drug NameTMC-558445
Drug Alias NameTMC-558445
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 inhibitors
TargetsCytochrome P450
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTibotec Pharmaceuticals, Ireland
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A